Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.370
+0.090 (2.74%)
Oct 9, 2026, 4:00 PM EDT - Market closed
IMDX Market Cap
IMDX has a market cap or net worth of $110.28 million as of October 9, 2026. It is the 24,758th most valuable company in the world and the 4,046th biggest in the United States. Its market cap has increased by 4.73% in one year.
Market Cap
110.28M
Enterprise Value
95.15M
1-Year Change
4.73%
Global Rank
Country Rank
#4,046 United States
Category
ChartMarket Cap Chart
Since January 4, 2016, IMDX's market cap has decreased from $228.70M to $110.28M, a decrease of -51.78%. That is a compound annual growth rate of -6.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 110.30M | -48.70% |
| Dec 31, 2025 | 215.00M | 436.16% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
| Jan 4, 2016 | 228.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 1.05B |
| OPKO Health | 1.03B |
| Fulgent Genetics | 598.18M |
| Myriad Genetics | 412.25M |
| Biodesix | 274.54M |
| Exagen | 203.98M |
| Burning Rock Biotech | 163.36M |
| Quantum Cyber | 113.49M |